StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sarepta Therapeutics (SRPT) halted, news pending
December 12, 2019 5:52 PM
Sarepta Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trading Halts
Next Articles
Sarepta Therapeutics (SRPT) PT Raised to $190 at Credit Suisse
December 13, 2019 7:44 AM
Sarepta Therapeutics (SRPT) PT Raised to $215 at RBC Capital; 'Vynodys Approval A Big Win'
December 13, 2019 6:19 AM
Sarepta Therapeutics (SRPT) Vyondys 53 Granted Accelerated FDA Approval to Treat DMD
December 12, 2019 5:49 PM